These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 907443)

  • 1. [Morphological and cytochemical investigation of Ehrlich ascites tumor cells of the solid form as compared with peritoneal exudate in mice (author's transl)].
    Bauer Z; Jurin M
    Arch Geschwulstforsch; 1977; 47(3):236-40. PubMed ID: 907443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymorphism of a tumor cell population and selective processes. II. Change in the correlation of the numbers of 2 subpopulations of Ehrlich-Ich Ph ascites tumor cells in mice under the action of cell-free ascitic fluid and its fractions].
    Fomina MM; Minenkova EA; Evseenko LS; Poroshenko GG
    Tsitologiia; 1978 Dec; 20(12):1401-6. PubMed ID: 734778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.
    Zardi L; Cecconi C; Barbieri O; Carnemolla B; Picca M; Santi L
    Cancer Res; 1979 Sep; 39(9):3774-9. PubMed ID: 383288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
    Bálint Z; Holczinger L
    Bull Cancer; 1984; 71(5):412-8. PubMed ID: 6525466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-glucuronidase in the ascitic fluid and serum of mice with Ehrlich ascites carcinoma].
    Nilius R; Peters JE
    Acta Biol Med Ger; 1967; 19(6):1011-6. PubMed ID: 5592031
    [No Abstract]   [Full Text] [Related]  

  • 6. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization of a cell surface ATPase from Ehrlich ascites carcinoma cells.
    Banerjee RK
    Indian J Biochem Biophys; 1979 Oct; 16(5):334-5. PubMed ID: 161549
    [No Abstract]   [Full Text] [Related]  

  • 8. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice.
    Lackovic V; Borecký L; Zschiesche W; Fahlbusch B; Schumann I
    Acta Virol; 1980 Jan; 24(1):45-54. PubMed ID: 6155777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells.
    Lackovic V; Borecký L
    Acta Biol Med Ger; 1979; 38(5-6):781-9. PubMed ID: 230674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low temperatures on the viability of Ehrlich ascites tumor cells.
    Kiricuta IC; Rişcă R; Morariu VV
    Morphol Embryol (Bucur); 1979; 25(4):361-4. PubMed ID: 160992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic cell spreading in rodent transplantable tumor models. I. Ehrlich tumor.
    Roveta G
    Boll Soc Ital Biol Sper; 1990 Mar; 66(3):287-93. PubMed ID: 2378737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course of mammary carcinoma. New immunopathologic parameters of evaluation. Experimental study in mice (MuMT). IV. Correlation of blood picture, splenogram and ascitic fluid cells].
    Behmer OA; Zanotto A; de Tolosa EM; Gomes DM
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):44-8. PubMed ID: 3441726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mesothelium changes following intraperitoneal implantation of ascites cells].
    Richter IE
    Verh Anat Ges; 1978; (72):657-60. PubMed ID: 746787
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative radiosensitivity of clonogenic tumor cells of the transplantable Ehrlich carcinoma in the ascitic and solid forms of growth].
    Konopliannikov AG; Kolesnikova AI; Lepekhina LA; Shteĭn LV
    Radiobiologiia; 1988; 28(5):623-5. PubMed ID: 3194492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Capacity for differentiation and normalization of tumor cell populations transplanted into the anterior chamber. IV. Ehrlich ascites carcinoma].
    Al-Rubey AK; Grigor'eva EG; Kulemina LIu; Shvemberger IN
    Tsitologiia; 1984 Dec; 26(12):1376-83. PubMed ID: 6528361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
    Nagy JA; Morgan ES; Herzberg KT; Manseau EJ; Dvorak AM; Dvorak HF
    Cancer Res; 1995 Jan; 55(2):376-85. PubMed ID: 7529135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.